Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Frank A. Bucci, Jr., M.D.
Age
55–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male of female, aged 55 or older
Scheduled to undergo phacoemulsification with the intraocular lens (IOL) implantation for the treatment of cataract
Willing to comply with study instructions, agree to make study appointments, and complete the course of the study
Must sign an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate
You may not be if
Known allergy or contraindication to the test article or its components
Presence of any ocular abnormality or significant illness that, in the investigator's opinion, could affect the subject's health
History of any illness that could be expected to interfere with the study
Any condition that, in the opinion of the investigator, would compromise the well-being of the subject or study
May not be currently using topical or systemic steroids or NSAIDs during the course of the study or within 4 weeks prior to enrolling in the study other than Dextenza and Omidria
Subject has active corneal, conjunctival, or canalicular infections, including: